Showing results (81-90 of 227) with videos related to
Sort By:
Pageof 23
American Heart Journal|December 18, 2007
Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progressionPaul A Gurbel, Rolf P Kreutz, Kevin P Bliden, et al.The American Journal of Cardiology|May 26, 2009
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stentingMark J Antonino, Elisabeth Mahla, Kevin P Bliden, et al.Kardiologia Polska|August 14, 2024
Can CYP2C19 genotyping improve antiplatelet therapy efficacy in real-life practice? Recent advancesUdaya S Tantry, Sahib Singh, Lekshmi Narayan Raghavakurup, et al.Current Problems in Cardiology|January 18, 2024
Safety and efficacy of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese non-diabetic patientsSahib Singh, Aakash Garg, Udaya S Tantry, et al.American Heart Journal|May 4, 2010
Hypothesis formulation from subgroup analyses: nonadherence or nonsteroidal anti-inflammatory drug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to "aspirin resistance"Charles H Hennekens, Wendy R Schneider, Patricia R Hebert, et al.Thrombosis and Haemostasis|December 17, 2013
Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomesYoung-Hoon Jeong, Kevin P Bliden, Alan R Shuldiner, et al.Expert Opinion on Investigational Drugs|December 24, 2019
Investigational drugs in phase II clinical trials for acute coronary syndromesAmit Rout, Ajaypaul Sukhi, Rahul Chaudhary, et al.Expert Review of Cardiovascular Therapy|October 4, 2012
Role of genotype-based personalized antiplatelet therapy in the era of potent P2Y₁₂ receptor inhibitorsMark J Antonino, Young-Hoon Jeong, Udaya S Tantry, et al.Current Vascular Pharmacology|January 19, 2018
Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians?Jae S Bae, Jong-Hwa Ahn, Udaya S Tantry, et al.The American Journal of Cardiology|May 11, 2024
P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary SyndromeSahib Singh, Aakash Garg, Udaya S Tantry, et al.Pageof 23